focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Cello Health PLC

10 Aug 2020 11:02

RNS Number : 6575V
Puma Investment Management Limited
10 August 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Puma Investment Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cello Health Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

07/08/2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Cello Health Plc Ord Gbp0.10

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,426,647

1.33%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,426,647

1.33%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Cello Health Plc Ord Gbp0.10

Sale

3632

 

£1.61

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

10/08/2020

Contact name:

Rachel Stansfield

(email: rachel.stansfield@pumainvestments.co.uk)

Telephone number*:

d:m:

+44 (0)20 7468 7966+44 (0)79 7036 2154

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETKZGMRLGLGGZG
Date   Source Headline
16th May 20114:35 pmRNSHolding in Company
16th May 20119:05 amRNSHolding in Company
11th May 20117:00 amRNSAdditional listing / TVR
28th Apr 201111:29 amRNSNotice of AGM and Annual Report and Accounts
11th Apr 20117:00 amRNSAcquisition
1st Apr 201112:47 pmRNSTotal Voting Rights
25th Mar 201112:25 pmRNSHolding(s) in Company
22nd Mar 20114:45 pmRNSHolding(s) in Company
22nd Mar 20114:20 pmRNSCompletion of Acquisition and Placing / TVR
15th Mar 20117:00 amRNSAcquisition and Placing
15th Mar 20117:00 amRNSFinal Results
24th Jan 201111:22 amRNSNotice of Results
19th Jan 20117:00 amRNSTrading update
27th Oct 20105:50 pmRNSHolding(s) in Company
14th Sep 20107:00 amRNSInterim Results
3rd Sep 20104:15 pmRNSHolding(s) in Company
1st Sep 20105:10 pmRNSHolding in Company
29th Jul 201012:24 pmRNSNotice of Results
22nd Jul 20107:00 amRNSBoard Appointment
22nd Jul 20107:00 amRNSPre-close trading update
19th Jul 201011:33 amRNSBoard Change
17th Jun 201010:00 amRNSHolding in Company
9th Jun 20107:00 amRNSDirector/PDMR Shareholding
7th Jun 201011:45 amRNSHolding(s) in Company
4th Jun 20101:10 pmRNSShare Option Grants
17th May 20101:15 pmRNSResult of AGM
17th May 20107:00 amRNSAGM Statement
30th Apr 20107:00 amRNSAdditional Listing / TVR
15th Apr 201012:44 pmRNSAnnual report & accounts & AGM notice
16th Mar 20107:00 amRNSFull Year Results
16th Feb 201011:41 amRNSNotice of Results
20th Jan 201010:30 amRNSHolding(s) in Company
19th Jan 20107:00 amRNSTrading Update
15th Sep 20097:00 amRNSInterim Results
10th Aug 200912:30 pmRNSChange in director's details
7th Aug 20099:45 amRNSChange of Adviser
5th Aug 20099:00 amRNSNotice of Results
3rd Jul 20097:00 amRNSTrading Statement
19th May 200912:46 pmRNSAGM Statement
15th May 20097:00 amRNSHolding(s) in Company
8th May 20092:55 pmRNSDigital capability widened
23rd Apr 20099:52 amRNSAnnual Report and Accounts
23rd Apr 20097:00 amRNSAdditional listing / TVR
16th Apr 20097:00 amRNSAdditional Listing/TVR
6th Apr 20097:00 amRNSDirector/PDMR Shareholding
2nd Apr 20095:28 pmRNSTransaction in Own Shares
1st Apr 20094:33 pmRNSTransaction in Own Shares
1st Apr 20094:33 pmRNSTransaction in Own Shares
27th Mar 20094:57 pmRNSTransaction in Own Shares
26th Mar 20094:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.